External irradiation models for intracranial 9L glioma studies

Journal of Experimental and Clinical Cancer Research

Volumn 29, Issue 1, 2010, Pages

  Vinchon Petit, Sandrine ^a,b   Jarnet, Delphine ^b   Jadaud, Eric ^b   Feuvret, Loc ^c   Garcion, Emmanuel ^a   Menei, Philippe ^a,d  

^a UNIVERSITÉ D'ANGERS   (France)

^b CENTRE PAUL PAPIN   (France)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^d ANGERS UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALOPECIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; BRAIN RADIATION; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CONTROLLED STUDY; EXTERNAL WHOLE BRAIN IRRADIATION; FEMALE; GLIOMA; MORBIDITY; NONHUMAN; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RAT; ANIMAL; BRAIN TUMOR; DISEASE MODEL; FISCHER 344 RAT; METHODOLOGY; SKULL IRRADIATION;

ANIMALS; BRAIN NEOPLASMS; CRANIAL IRRADIATION; DISEASE MODELS, ANIMAL; DOSE FRACTIONATION; FEMALE; GLIOMA; RATS; RATS, INBRED F344;

EID: 78049472811     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/1756-9966-29-142     Document Type: Article

References (22)

1. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. R Stupp WP Mason MJ van den Bent M Weller B Fisher MJ Taphoorn K Belanger AA Brandes C Marosi U Bogdahn J Curschmann RC Janzer SK Ludwin T Gorlia A Allgeier D Lacombe JG Cairncross E Eisenhauer RO Mirimanoff European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups; National Cancer Institute of Canada Clinical Trials Group, N Engl J Med 2005 352 10 987 96 10.1056/NEJMoa043330 15758009
2. Combined modality therapy of operated astrocytomas grade III and IV. Confirmation of the value of postoperative irradiation and lack of potentiation of bleomycin on survival time: a prospective multicenter trial of the Scandinavian Glioblastoma Study Group. K Kristiansen S Hagen T Kollevold,, et al. Cancer 1981 47 4 649 52 10.1002/1097-0142(19810215)47:4<649::AID- CNCR2820470405>3.0.CO;2-W 6164465
3. Cancer Care Ontario Practice Guidelines Initiative Neuro-Oncology Disease Site Group: Radiotherapy for newly diagnosed malignant glioma in adults: a systematic review. N Laperriere L Zuraw G Cairncross, Radiother Oncol 2002 64 3 259 73 10.1016/S0167-8140(02)00078-6 12242114
4. Phase III trial of chemotherapy plus radiotherapy compared with radiotherapy alone for pure and mixed anaplastic oligodendroglioma: Intergroup Radiation Therapy Oncology Group Trial 9402. G Cairncross B Berkey E Shaw,, et al. J Clin Oncol 2006 24 18 2707 14 10.1200/JCO.2005.04.3414 16782910
5. Radiation therapy for glial tumors: Technical aspects and clinical indications. G Kantor A Laprie A Huchet H Loiseau C Dejean JJ Mazeron, Cancer Radiother 2008 12 6-7 687 94 18926759
6. Influence of 5-fluorouracil-loaded microsphere formulation on efficient rat glioma radiosensitization. VG Roullin M Mege L Lemaire JP Cueyssac MC Venier-Julienne P Menei E Gamelin JP Benoit, Pharm Res 2004 21 9 1558 63 10.1023/B:PHAM.0000041448.22771.48 15497679
7. Irradiated tumor cell vaccine for treatment of an established glioma. I. Successful treatment with combined radiotherapy and cellular vaccination. MR Graf RM Prins WT Hawkins RE Merchant, Cancer Immunol Immunother 2002 51 4 179 89 10.1007/s00262-002-0269-3 12012105
8. Effect of spirogermanium and radiation therapy on the 9L rat brain tumor model. BF Kimler DF Martin RG Evans RA Morantz TS Vats, NCI Monogr 1988 6 115 8 3352753
9. Combination of radiation therapy and intracranial bleomycin in the 9L rat brain tumor model. BF Kimler DF Martin RG Evans RA Morantz TS Vats, Int J Radiat Oncol Biol Phys 1990 18 5 1115 21 1693363
10. Combination of aziridinylbenzoquinone and cis-platinum with radiation therapy in the 9L rat brain tumor model. BF Kimler C Liu RG Evans RA Morantz, Int J Radiat Oncol Biol Phys 1993 26 3 445 50 8514542
11. Effect of pentobarbital on normal brain protection and on the response of 9L rat brain tumor to radiation therapy. BF Kimler C Liu RG Evans RA Morantz, J Neurosurg 1993 79 4 577 83 10.3171/jns.1993.79.4.0577 8410227
12. Radiation-induced cognitive dysfunction: an experimental model in the old rat. I Lamproglou QM Chen G Boisserie JJ Mazeron M Poisson F Baillet M Le Poncin JY Delattre, Int J Radiat Oncol Biol Phys 1995 31 1 65 70 7995769
13. Enhancement of the efficacy of x-irradiation by pentobarbital in a rodent brain-tumor model. JJ Olson R Friedman K Orr,, et al. J Neurosurg 1990 72 5 745 8 10.3171/jns.1990.72.5.0745 2324799
14. Characterization and detection of experimental rat gliomas using magnetic resonance imaging. A Vonarbourg A Sapin L Lemaire,, et al. Magma 2004 17 3-6 133 9 10.1007/s10334-004-0049-5 15503254
15. Effects of xenon anesthesia on cerebral blood flow in humans: a positron emission tomography study. RM Laitio KK Kaisti JW Låangsjö S Aalto E Salmi A Maksimow R Aantaa V Oikonen H Sipilä R Parkkola H Scheinin, Anesthesiology 2007 106 6 1128 33 10.1097/01.anes.0000267596.57497.92 17525587
16. Molecular and cellular response of the most extensively used rodent glioma models to radiation and/or cisplatin. Z Bencokova L Pauron C Devic,, et al. J Neurooncol 2008 86 13 21 10.1007/s11060-007-9433-0 17611717
17. Fractionated radiosurgery for 9L gliosarcoma in the rat brain. JH Kim MS Khil A Kolozsvary,, et al. Int J Radiat Oncol Biol Phys 1999 45 4 1035 40 10571213
18. Local delivery of ferrociphenol lipid nanocapsules followed by external radiotherapy as a synergistic treatment against intracranial 9L glioma xenograft. E Allard C Passirani D Jarnet S Petit A Vessières G Jaouen J-P Benoit, Pharm Res 2010 27 1 56 64 10.1007/s11095-009-0006-0 19908129
19. Toxicology and pharmacokinetic study of orally administered 5-iodo-2-pyrimidinone-2'deoxyribose (IPdR) × 28 days in Fischer-344 rats: impact on the initial clinical phase I trial design of IPdR-mediated radiosensitization. TJ Kinsella MT Kinsella S Hong,, et al. Cancer Chemother Pharmacol 2008 61 2 323 34 10.1007/s00280-007-0518-4 17562042
20. Radiosensitization of rat glioma with bromodeoxycytidine and adenovirus expressing herpes simplex virus-thymidine kinase delivered by slow, rate-controlled positive pressure infusion. D Brust J Feden J Farnsworth,, et al. Cancer Gene Ther 2000 7 5 778 88 10.1038/sj.cgt.7700168 10830725
21. MDA-7/IL-24 plus radiation enhance survival in animals with intracranial primary human GBM tumors. A Yacoub H Hamed L Emdad,, et al. Cancer Biol Ther 2008 7 6 917 33 10.4161/cbt.7.6.5928 18376144
22. In vivo evaluation of intracellular drug-nanocarriers infused into intracranial tumours by convection-enhanced delivery: distribution and radiosensitisation efficacy. S Vinchon-Petit D Jarnet A Paillard JP Benoit E Garcion P Menei, J Neurooncol 2010 97 2 195 205 Epub 2009 Sep 22 10.1007/s11060-009-0012-4 19768659